Agilent Technologies Inc (A) Shares Bought by Pegasus Partners Ltd.

Pegasus Partners Ltd. increased its stake in Agilent Technologies Inc (NYSE:A) by 33.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 20,111 shares of the medical research company’s stock after acquiring an additional 5,092 shares during the period. Pegasus Partners Ltd.’s holdings in Agilent Technologies were worth $1,347,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Victory Capital Management Inc. lifted its position in Agilent Technologies by 8.2% during the third quarter. Victory Capital Management Inc. now owns 3,330,488 shares of the medical research company’s stock valued at $213,817,000 after buying an additional 253,250 shares in the last quarter. Wells Fargo & Company MN lifted its position in Agilent Technologies by 27.6% during the third quarter. Wells Fargo & Company MN now owns 2,184,502 shares of the medical research company’s stock valued at $140,244,000 after buying an additional 473,047 shares in the last quarter. Impax Asset Management LTD lifted its position in Agilent Technologies by 14.9% during the third quarter. Impax Asset Management LTD now owns 2,106,322 shares of the medical research company’s stock valued at $135,226,000 after buying an additional 272,571 shares in the last quarter. Legal & General Group Plc lifted its position in Agilent Technologies by 2.9% during the third quarter. Legal & General Group Plc now owns 1,690,240 shares of the medical research company’s stock valued at $108,512,000 after buying an additional 46,962 shares in the last quarter. Finally, Schwab Charles Investment Management Inc. lifted its position in Agilent Technologies by 1.4% during the third quarter. Schwab Charles Investment Management Inc. now owns 1,332,267 shares of the medical research company’s stock valued at $85,532,000 after buying an additional 18,189 shares in the last quarter.

Shares of Agilent Technologies Inc (NYSE:A) opened at $68.34 on Wednesday. The stock has a market cap of $22,083.55, a P/E ratio of 28.87, a PEG ratio of 2.07 and a beta of 1.28. Agilent Technologies Inc has a 12 month low of $50.09 and a 12 month high of $75.00. The company has a debt-to-equity ratio of 0.37, a quick ratio of 2.85 and a current ratio of 3.30.

Agilent Technologies (NYSE:A) last posted its quarterly earnings data on Monday, November 20th. The medical research company reported $0.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.62 by $0.05. The company had revenue of $1.19 billion for the quarter, compared to analyst estimates of $1.17 billion. Agilent Technologies had a net margin of 15.30% and a return on equity of 16.95%. The business’s quarterly revenue was up 7.0% on a year-over-year basis. During the same quarter last year, the firm posted $0.59 earnings per share. sell-side analysts forecast that Agilent Technologies Inc will post 2.58 EPS for the current fiscal year.

A number of research analysts have weighed in on the stock. Cowen reaffirmed a “hold” rating and set a $70.00 price target on shares of Agilent Technologies in a research report on Wednesday, November 22nd. Evercore ISI assumed coverage on shares of Agilent Technologies in a research report on Wednesday, January 3rd. They set an “outperform” rating and a $75.00 price target on the stock. Robert W. Baird reaffirmed a “buy” rating and set a $72.00 price target on shares of Agilent Technologies in a research report on Friday, November 24th. Zacks Investment Research upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating and set a $76.00 price objective on the stock in a research note on Tuesday, October 31st. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Agilent Technologies to $75.00 and gave the company an “overweight” rating in a research note on Tuesday, November 21st. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $69.25.

In related news, insider Patrick Kaltenbach sold 7,358 shares of Agilent Technologies stock in a transaction on Wednesday, November 22nd. The shares were sold at an average price of $69.28, for a total value of $509,762.24. Following the completion of the sale, the insider now owns 72,862 shares in the company, valued at $5,047,879.36. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Michael R. Mcmullen sold 43,703 shares of Agilent Technologies stock in a transaction on Friday, January 5th. The stock was sold at an average price of $70.00, for a total transaction of $3,059,210.00. Following the completion of the sale, the chief executive officer now owns 302,837 shares of the company’s stock, valued at approximately $21,198,590. The disclosure for this sale can be found here. Insiders have sold 219,991 shares of company stock worth $15,468,795 in the last quarter.

COPYRIGHT VIOLATION WARNING: “Agilent Technologies Inc (A) Shares Bought by Pegasus Partners Ltd.” was first published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this piece on another domain, it was illegally copied and republished in violation of international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.dispatchtribunal.com/2018/02/14/agilent-technologies-inc-a-shares-bought-by-pegasus-partners-ltd.html.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.

Want to see what other hedge funds are holding A? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Agilent Technologies Inc (NYSE:A).

Institutional Ownership by Quarter for Agilent Technologies (NYSE:A)

Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply